This observational cohort study included 232 patients with a first-ever ischemic stroke presenting to a Dutch Comprehensive Stroke Center. The analysis compared patients with a migration background against those without a migration background regarding presentation timing, reperfusion therapy, and clinical characteristics. The study was conducted at a single center in the Netherlands.
Patients with a migration background were more likely to present outside the therapeutic time window, with an odds ratio of 1.90 (95% CI 1.05-3.45). Specifically, 53.2% of this group presented late compared to 37.1% of the comparator group. Conversely, endovascular thrombectomy (EVT) was less frequent in patients with a migration background (8.1% vs 22.4%, OR 0.28, 95% CI 0.10-0.75).
Demographic and stroke characteristics differed between groups. Patients with a migration background were younger (66.6 vs 71.2 years) and had a higher prevalence of diabetes (27.4% vs 15.9%). Small vessel disease was more common in this group (69.4% vs 48.2%), whereas cardio-embolism was less common (4.8% vs 15.3%). Sex distribution was similar (59.7% vs 60.6% male). Door-to-treatment time (38min vs 30min), door-to-needle time (35min vs 26min), and door-to-groin time (64min vs 54min) showed no significant differences.
Safety data, including adverse events, were not reported. The study is limited by its single-center design. Associations observed may reflect prehospital and within-hospital barriers rather than inherent patient factors. Further insight is needed to address facilitators and barriers for appropriate management of this population.
View Original Abstract ↓
Objective: To assess ethnic disparities in time to hospital presentation, use of acute reperfusion therapies, and in-hospital treatment times among patients presenting with stroke in a Dutch emergency department. Methods: In this single-centre observational cohort study, we included patients with a first-ever ischemic stroke between September 2020 and September 2021. Patients were categorized by ethnicity (with or without migration background). Demographic and stroke characteristics were compared between groups. Outcomes included: rates of presentation outside therapeutic time window, acute reperfusion therapy (intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT)), and, when applicable, door-to-treatment time (DTTT), with a door-to-needle time (DTNT) and door-to-groin time (DTGT) for IVT and EVT respectively. Univariable and multivariable linear and logistic regression analyses were performed, adjusted for age, sex, and NIHSS at presentation, where appropriate. Results: A total of 232 patients were included, of whom 62 (26.7%) had a migration background. These patients were younger (66.6 vs 71.2 years) and more frequently had diabetes (27.4% vs 15.9%). Sex distribution was similar (59.7% vs 60.6% male). Stroke etiology differed between groups with less cardio-embolism (4.8% vs 15.3%) and more small vessel disease (69.4% vs 48.2%) among patients with a migration background. These latter patients presented more often outside the therapeutic time window (53.2% vs 37.1%; OR 1.90; 95% CI 1.05-3.45). EVT was less frequently performed in patients with a migration background compared to those without (8.1% vs 22.4%; OR 0.28; 95% CI 0.10-0.75). There were no significant differences in treatment times (DTTT 38min vs 30min, DTNT 35min vs 26min, DTGT 64min vs 54min). Conclusion: Patients with a migration background were more likely to present outside the therapeutic time window and had a lower rate of EVT. In order to improve access for these patients, more insight into prehospital and within hospital barriers and facilitators for appropriate management are needed.